Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: Single center experience over a one-year period;Sistemik jüvenil idiyopatik artrite ikincil gelişen makrofaj aktivasyon sendromu olguları: Tek merkezin bir yıllık deneyim sonuçları

Turk Pediatri Arsivi

Volumn 50, Issue 4, 2015, Pages 206-210

  Barut, Kenan ^a   Yücel, Gözde ^a   Sinoplu, Ada Bulut ^a   Şahin, Sezgin ^a   Adroviç, Amra ^a   Kasapçopur, Özgür ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Juvenile idiopathic arthritis; Macrophage activation syndrome; Systemic

Indexed keywords

CANAKINUMAB; CYCLOSPORIN A; FERRITIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANEMIA; ARTICLE; BODY TEMPERATURE; CLINICAL ARTICLE; ERYTHROCYTE SEDIMENTATION RATE; HEPATOSPLENOMEGALY; HUMAN; HYPERTRIGLYCERIDEMIA; MACROPHAGE ACTIVATION SYNDROME; PLASMAPHERESIS; RHEUMATIC DISEASE; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS;

EID: 84948777717     PISSN: 13060015     EISSN: 13086278     Source Type: Journal    
DOI: 10.5152/TurkPediatriArs.2015.3299     Document Type: Article

References (17)

1. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
2. Minoia F, Davì S, Horne A, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 2014; 66: 3160-9. [CrossRef ]
3. Zhang M, Behrens EM, Atkinson TP, Shakoory B, Grom AA, Cron RQ. Genetic defects incytolysis in macrophage activation syndrome. Curr Rheumatol Repn 2014; 16: 439. [CrossRef ]
4. Pachlopnik Schmid J, Cote M, Menager MM, et al. Inherited defects in lymphocyte cytotoxic activity. Immunol Rev 2010; 235: 10-23. [CrossRef ]
5. Terrell CE, Jordan MB. Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8+ T cells and dendritic cells. Blood 2013; 121: 5184-91. [CrossRef ]
6. Kaufman KM, Linghu B, Szustakowski JD, et al. Whole exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheumatol 2014; 66: 3486-95. [CrossRef ]
7. Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007; 34: 1133-8.
8. Bleesing J, Prada A, Siegel DM, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 965-71. [CrossRef ]
9. Pringe A, Trail L, Ruperto N, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? Lupus 2007; 16: 587-92. [CrossRef ]
10. Latino GA, Manlhiot C, Yeung RS, Chahal N, McCrindle BW. Macrophage activation syndrome in the acute phase of Kawasaki disease. J Pediatr Hematol Oncol 2010; 32: 527-31. [CrossRef ]
11. Atteritano M, David A, Bagnato G, et al. Haemophagocytic syndrome in rheumatic patients. A systematic review. Eur Rev Med Pharmacol Sci 2012; 16: 1414-24.
12. Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 2012; 13: 289-98. [CrossRef ]
13. Wang W, Gong F, Zhu W, Fu S, Zhang Q. Macrophage activation syndrome in Kawasaki disease: more common than we thought? Semin Arthritis Rheum 2015; 44: 405-10. [CrossRef ]
14. Bennett TD, Fluchel M, Hersh AO, et al. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis. Arthritis Rheum 2012; 64: 4135-42. [CrossRef ]
15. Vilaiyuk S, Sirachainan N, Wanitkun S, Pirojsakul K, Vaewpanich J. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review. Clin Rheumatol 2013; 32: 899-4. [CrossRef ]
16. Athreya BH. Is macrophage activation syndrome a new entity? Clin Exp Rheumatol 2002; 20: 121-3.
17. Ramanan AV, Schneider R. Macrophage activation syndrome-what’s in a name! J Rheumatol 2003; 30: 2513-6.